Lisa Butler
Lisa Butler
Verified email at - Homepage
Cited by
Cited by
Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo
LM Butler, DB Agus, HI Scher, B Higgins, A Rose, C Cordon-Cardo, ...
Cancer research 60 (18), 5165-5170, 2000
The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin
LM Butler, X Zhou, WS Xu, HI Scher, RA Rifkind, PA Marks, VM Richon
Proceedings of the National Academy of Sciences 99 (18), 11700-11705, 2002
Dual roles of PARP-1 promote cancer growth and progression
MJ Schiewer, JF Goodwin, S Han, JC Brenner, MA Augello, JL Dean, ...
Cancer discovery 2 (12), 1134-1149, 2012
Androgen receptor inhibits estrogen receptor-α activity and is prognostic in breast cancer
AA Peters, G Buchanan, C Ricciardelli, T Bianco-Miotto, MM Centenera, ...
Cancer research 69 (15), 6131-6140, 2009
Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention
LM Butler, Y Perone, J Dehairs, LE Lupien, V de Laat, A Talebi, M Loda, ...
Advanced drug delivery reviews 159, 245-293, 2020
Targeting the androgen receptor: improving outcomes for castration-resistant prostate cancer
HI Scher, G Buchanan, W Gerald, LM Butler, WD Tilley
Endocrine-related cancer 11 (3), 459-476, 2004
Therapeutic response to CDK4/6 inhibition in breast cancer defined by ex vivo analyses of human tumors
JL Dean, AK McClendon, TE Hickey, LM Butler, WD Tilley, AK Witkiewicz, ...
Cell cycle 11 (14), 2756-2761, 2012
Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease
LA Selth, S Townley, JL Gillis, AM Ochnik, K Murti, RJ Macfarlane, KN Chi, ...
International Journal of Cancer 131 (3), 652-661, 2012
Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer
G Zadra, CF Ribeiro, P Chetta, Y Ho, S Cacciatore, X Gao, S Syamala, ...
Proceedings of the National Academy of Sciences 116 (2), 631-640, 2019
Maximizing the therapeutic potential of HSP90 inhibitors
LM Butler, R Ferraldeschi, HK Armstrong, MM Centenera, P Workman
Molecular cancer research 13 (11), 1445-1451, 2015
The histone deacetylase inhibitor, CBHA, inhibits growth of human neuroblastoma xenografts in vivo, alone and synergistically with all-trans retinoic acid
DC Coffey, MC Kutko, RD Glick, LM Butler, G Heller, RA Rifkind, PA Marks, ...
Cancer research 61 (9), 3591-3594, 2001
Cancer-associated fibroblasts—heroes or villains?
KA Gieniec, LM Butler, DL Worthley, SL Woods
British journal of cancer 121 (4), 293-302, 2019
Minireview: The contribution of different androgen receptor domains to receptor dimerization and signaling
MM Centenera, JM Harris, WD Tilley, LM Butler
Molecular endocrinology 22 (11), 2373-2382, 2008
Global levels of specific histone modifications and an epigenetic gene signature predict prostate cancer progression and development
T Bianco-Miotto, K Chiam, G Buchanan, S Jindal, TK Day, M Thomas, ...
Cancer epidemiology, biomarkers & prévention 19 (10), 2611-2622, 2010
Tumour fatty acid metabolism in the context of therapy resistance and obesity
AJ Hoy, SR Nagarajan, LM Butler
Nature Reviews Cancer 21 (12), 753-766, 2021
Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase
LM Butler, Y Webb, DB Agus, B Higgins, TR Tolentino, MC Kutko, ...
Clinical cancer research 7 (4), 962-970, 2001
Peptidomimetic targeting of critical androgen receptor–coregulator interactions in prostate cancer
P Ravindranathan, TK Lee, L Yang, MM Centenera, L Butler, WD Tilley, ...
Nature communications 4 (1), 1923, 2013
Ex vivo culture of human prostate tissue and drug development
MM Centenera, GV Raj, KE Knudsen, WD Tilley, LM Butler
Nature Reviews Urology 10 (8), 483-487, 2013
Circulating microRNAs predict biochemical recurrence in prostate cancer patients
LA Selth, SL Townley, AG Bert, PD Stricker, PD Sutherland, LG Horvath, ...
British journal of cancer 109 (3), 641-650, 2013
Evidence for Efficacy of New Hsp90 Inhibitors Revealed by Ex Vivo Culture of Human Prostate Tumors
MM Centenera, JL Gillis, AR Hanson, S Jindal, RA Taylor, GP Risbridger, ...
Clinical Cancer Research 18 (13), 3562-3570, 2012
The system can't perform the operation now. Try again later.
Articles 1–20